Adoption of triplet therapy and clinical outcomes in routine practice among newly diagnosed multiple myeloma patients not receiving frontline stem cell transplant in the USA.

Hari, Parameswaran; Blazer, Marlo; Raju, Aditya; Farrelly, Eileen; Labotka, Richard; Skacel, Tomas; Romanus, Dorothy

Hari, Parameswaran; Blazer, Marlo; Raju, Aditya; Farrelly, Eileen; Labotka, Richard; Skacel, Tomas; Romanus, Dorothy.

Affiliation

Hari P; a Department of Medicine , Medical College of Wisconsin , Milwaukee , WI , USA.
Blazer M; b Xcenda, LLC , Palm Harbor , FL , USA.
Raju A; b Xcenda, LLC , Palm Harbor , FL , USA.
Farrelly E; b Xcenda, LLC , Palm Harbor , FL , USA.
Labotka R; c Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited , Cambridge , UK.
Skacel T; c Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited , Cambridge , UK.
Romanus D; c Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited , Cambridge , UK.

Expert Rev Hematol ; 12(1): 71-79, 2019 01.

Article de En | MEDLINE | ID: mdl-30513016

Sujet(s)
Mots clés

Newly diagnosed multiple myeloma; induction therapy; triplet therapy

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Transplantation de cellules souches / Myélome multiple Type d'étude: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Female / Humans / Male Pays/Région comme sujet: America do norte Langue: En Journal: Expert Rev Hematol Sujet du journal: HEMATOLOGIA Année: 2019 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google